| | | December 31, | | ||||
| | | 2016 | | 2015 | | ||
| Deferred tax assets: | | | | | | | |
| Net operating loss carryforwards | | $ | 87,267 | | $ | 91,365 | |
| Research credit carryforwards | | | 14,322 | | | 13,884 | |
| Other, net | | | 2,637 | | | 3,417 | |
| Deferred revenue | | | | | | | |
| Total deferred tax assets | | | 104,226 | | | 108,666 | |
| Valuation allowance | | | (104,226) | | | (108,666) | |
| Net deferred tax assets | | $ | | | $ | | |
| | | Year Ending December 31, | | |||||||
| | | 2016 | | 2015 | | 2014 | | |||
| Computed at 34% | | $ | 1,758 | | $ | (3,840) | | $ | (839) | |
| State taxes | | | (187) | | | (268) | | | 592 | |
| Book gains (losses) not currently benefited | | | (4,439) | | | 2,740 | | | 454 | |
| Other | | | 659 | | | (20) | | | 235 | |
| Revaluation of warrant liability | | | (280) | | | 1,534 | | | (346) | |
| Research and development credits | | | (252) | | | (146) | | | (97) | |
| Net operating loss carryforward expirations | | | 2,741 | | | | | | | |
| Total | | $ | | | $ | | | $ | (1) | |